Skip to main content
. 2013 Dec 28;19(48):9189–9197. doi: 10.3748/wjg.v19.i48.9189

Figure 2.

Figure 2

Proposed algorithm for allocation and management of anti-hepatitis B core positive liver grafts. Such grafts should be first offered to hepatitis B surface antigen positive, then to anti-hepatitis B core (HBc) and/or anti-hepatitis B surface (HBs) positive and lastly to hepatitis B virus naive (both anti-HBc and anti-HBs negative) recipients[79]. LT: Liver transplantation; HBIG: Hepatitis B immunoglobulin; LAM: Lamivudine.